This activity is supported by educational grants from AbbVie, Allergan Inc.,
Dova Pharmaceuticals, Gilead, Intercept Pharmaceuticals, Inc.,
Mallinckrodt Pharmaceuticals, and Salix Pharmaceuticals.

‚Äč

Jointly provided by the Annenberg Center for Health Sciences 
at Eisenhower, the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute.

  • Facebook Social Icon
  • Twitter Social Icon

© 2020 GI and Liver Association of the Americas

7TH ANNUAL

DALLAS

CONFERENCE

Postponed Until Further Notice

Arlington, Texas

 ABOUT 

This CME conference aims to deliver a comprehensive educational update that highlights the most clinically relevant advances in chronic liver and gastrointestinal (GI) diseases. The 1.5-day conference will have a strong focus on viral hepatitis, non-alcoholic steatohepatitis, primary biliary cirrhosis, complications of cirrhosis, including hepatic encephalopathy and thrombocytopenia, hepatocellular carcinoma, and irritable bowel syndrome.

 COURSE DIRECTORS

 

Mack Mitchell, MD

Nancy and Jeremy Halbreich Professor of Gastroenterology

University of Texas

Southwestern Medical Center

Dallas, Texas

Lawrence Schiller, MD

Program Director, Gastroenterology Fellowship

Baylor University Medical Center

Dallas, Texas

 SOCIETY ENDORSEMENTS 

 AGENDA OVERVIEW 

DAY ONE

12:00 PM   Lunch

12:50 PM   Welcome

1:00 PM     Plenary Session I

3:15 PM     Break

3:30 PM     Plenary Session II

5:15 PM     Day 1 Wrap-up

5:30 PM     Welcome Reception  

DAY TWO

7:30 AM     Breakfast

8:20 AM     Welcome

8:30 AM     Plenary Session III

10:30 AM   Break

10:45 AM   Parallel Sessions

11:45 AM   Lunch

1:00 PM     Plenary Session IV

3:05 PM     Break

3:20 PM     Plenary Session V

4:40 PM     Closing Remarks 

 VENUE 

Live! By Loews

1600 East Randol Mill Road

Arlington, Texas 76011